Welcome to our dedicated page for Procore Technologies SEC filings (Ticker: PCOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Procore Technologies, Inc. filings document a public SaaS company whose common stock trades on the New York Stock Exchange under PCOR. Its reports and current filings cover operating and financial results for a subscription-based construction management platform, including revenue performance, customer metrics, guidance, and capital-structure disclosures.
Proxy statements and Form 8-K reports also record governance matters, director and executive officer appointments, committee assignments, compensation arrangements, stockholder voting items, risk factors, and material events tied to Procore's platform, business operations, and reporting obligations.
Procore Technologies chairman Craig F. Courtemanche Jr. reported a mix of stock option exercises, share sales, and structured financing tied to his holdings. He exercised stock options for 56,122 shares of Common Stock at $2.42 per share, increasing his direct stake, and then sold 42,421 shares at $45.29 and 13,701 shares at $44.69 in open-market transactions. The sales were made under a pre-arranged Rule 10b5-1 trading plan dated December 9, 2025, and left him with 975,826 directly held shares. Separately, the Craig F. Courtemanche and Hillary Courtemanche Family Trust and the Courtemanche 2021 Irrevocable Trust entered into revolving loan and collar transactions with a bank covering 1,700,000 pledged shares, using European call and put options with strike prices of $60.9986 and $37.5716 and expirations in June 2029 for general liquidity purposes, while generally retaining voting and dividend rights on the pledged stock.
Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing an intended sale of 56,122 shares of Common Stock on 06/10/2026 related to a stock option exercise. The filing lists prior dispositions of 56,122 shares on 05/11/2026 and 04/10/2026 with dollar amounts shown alongside each transaction.
Griffith William J.G. reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director William J.G. Griffith reported an award of 4,712 restricted stock units (RSUs) of common stock at a price of $0.00 per share. These RSUs vest in full at the company’s 2027 annual meeting of stockholders, subject to his continued board service.
Settlement of the RSUs into common stock has been deferred until the earlier of 90 days after his service ends or a change in control. According to the footnotes, any proceeds from sales of shares issued upon RSU settlement will be transferred to ICONIQ Capital, LLC, and Griffith disclaims beneficial ownership except to the extent of any pecuniary interest.
The Form 4 also lists sizeable indirect holdings of Procore common stock through multiple ICONIQ Strategic Partners funds and estate-planning trusts, with a post-transaction direct and RSU-related position of 3,249,258 shares reported, reflecting his broad economic exposure rather than a new open‑market trade.
SMITH GRAHAM reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director Graham Smith received an equity award of 4,712 restricted stock units (RSUs), each representing one share of common stock upon settlement. After this grant, he holds 54,381 shares (including the RSUs reported in the filing).
All 4,712 RSUs are scheduled to vest on the date of Procore’s 2027 annual meeting of stockholders, or immediately before that date if his board service ends at that meeting due to not being re-elected or not standing for re-election. Smith has elected to defer settlement of the vested RSUs into common stock until the earlier of 90 days after his service terminates or a change in control of the company.
Procore Technologies director Kathryn Bueker received an equity award in the form of restricted stock units. She was granted 4,712 shares of common stock at no cost, bringing her direct holdings to 18,193 shares after the transaction.
The 4,712 RSUs will vest 100% on the date of Procore’s 2027 annual meeting of stockholders, or immediately before that meeting if her service ends at that time, conditioned on her continued board service through the vesting date. She has elected to defer delivery of the underlying shares until the earlier of 90 days after her service terminates or a change in control, making this a compensation-related, non-cash acquisition rather than an open-market purchase.
Misra Vishal reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director Vishal Misra received an equity award covering 603 shares of common stock at no cash cost, in the form of restricted stock units. The RSUs are scheduled to vest 100% at the company’s 2027 annual meeting of stockholders, subject to continued board service, bringing his reported holdings to 10,623 shares.
Chapple Erin reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director Erin Chapple received a grant of 4,712 shares of common stock in the form of restricted stock units at no cash cost. These RSUs vest in full at the company’s 2027 annual meeting of stockholders, subject to her continued board service. After this award, she directly holds 19,555 shares of Procore common stock.
HOVSEPIAN RONALD W reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director Ronald W. Hovsepian received 2,330 shares of common stock in the form of restricted stock units as a compensation grant. The RSUs vest in full at the company’s 2027 annual meeting of stockholders, subject to his continued board service, bringing his direct holdings to 9,527 shares.
CALDWELL NANCI reported acquisition or exercise transactions in this Form 4 filing.
Procore Technologies director Nanci Caldwell received an equity award of 4,712 restricted stock units (RSUs) of common stock. The RSUs vest 100% at the company’s 2027 annual meeting of stockholders, subject to continued board service, and Caldwell elected to defer delivery of the shares until after service ends or a change in control. Following this grant, she beneficially owns 63,871 shares of common stock.
Courtemanche Craig F. Jr. reported acquisition or exercise transactions in this Form 4 filing.
PROCORE TECHNOLOGIES, INC. director and Chairman Craig F. Courtemanche Jr. received a grant of 4,712 shares of common stock in the form of restricted stock units (RSUs) at a price of $0.0000 per share. These RSUs vest 100% on the date of the issuer's 2027 annual meeting of stockholders, subject to his continued service through that date.
He has elected to defer receipt of the underlying common stock until the earlier of 90 days after his service ends or a change in control. After this award, he holds 919,704 shares directly, with additional indirect holdings reported through his spouse and several family trusts. The filing does not show any open-market purchases or sales, only this equity award and updated ownership totals.